Selank
Selank: a Russian peptide studied for anxiety, its FDA status, the one small human comparison study, and the safety information FDA says is missing.
Not FDA-approved · Evidence grade C · Reviewed
Not approved by the FDA for human use. Not for human consumption. This page describes Selank only to explain its regulatory status, what has been studied and its known risks. Drawline does not recommend obtaining or using it. Disclaimer
2026 update2026: FDA moved several withdrawn nominations, including Semax, Selank, DSIP and thymosin alpha 1, to a table of withdrawn nominations while keeping its safety notes. Leaving the safety-risk list does not make a substance approved or eligible for compounding.See every change in the 2026 tracker ›- Not approvedAnxietyStudied in Russia; not approved
Selank (TP-7, tuftsin analog). Synthetic peptide.
CNot FDA-approved. Evidence grade C: limited, early or dated human data.
What is Selank?
Selank is a synthetic seven-amino-acid peptide based on tuftsin, a fragment of an immune protein. It is promoted for anxiety and focus.
Is Selank FDA-approved?
Not approved for any use in the United States. FDA had listed it among bulk substances that may present significant safety risks in compounding. The nomination was later withdrawn, and in 2026 FDA moved it to a table of withdrawn nominations while keeping its safety notes. Leaving that list does not make it approved or eligible for compounding. It was not on the agenda of the July 2026 advisory committee and is not covered by the October 2026 HHS draft policy. In 2020 FDA cited a pharmacy for compounding it.
What does the evidence show for Selank?
One small Russian study from 2008 compared it with a benzodiazepine in 62 people with anxiety or neurasthenia and reported similar effects. It does not report randomization or blinding. The rest is animal research. A 2021 review in the Journal of Clinical Pharmacology called it a poorly studied Russian drug sold to US consumers.
What are the known risks of Selank?
FDA says it lacks important information about safety in people and flags possible immune reactions. Lab work suggests it acts on the same brain receptors as benzodiazepines; combining the two has not been studied. Sport: it is not named on the World Anti-Doping Code Prohibited List. The list also bans unapproved substances in general, and from 2027 names unapproved peptides there, so athletes should check with their anti-doping agency.
How is Selank measured?
Usually sold as a nasal spray or as a powder vial. For a vial, the Mix mode shows the arithmetic. Products sold online as "research use only" have no assurance of identity, dose or sterility. The calculator can do the arithmetic for any vial, but it cannot tell you what is actually in one.
Sources: FDA: bulk drug substances that may present significant safety risks; FDA warning letter: compounding of unapproved peptides, 2020; Selank in generalized anxiety disorder (2008); Journal of Clinical Pharmacology review (2021); WADA: 2026 Prohibited List; USADA: athlete advisory on the 2027 Prohibited List. This profile does not recommend any dose or use.
For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.
Keep reading
Spot a mistake or an out-of-date fact? Report an error. We check every report against the sources.